Figure 5. The site view of the interactions between leader peptide (shown as green) and the designed PEPTIDE 3 (shown as orange) with the HLA-E proteins (HLA-E protein is shown as purple, CD94 protein is shown as yellow, NKG2A protein is shown as blue). All hydrogen bonds and residues are labeled. (A) the site view of leader peptide docked with HLA-E; (B) the site view of PEPTIDE 3 with HLA-E.